Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Overview of beginner-friendly HYSA options, focusing on accessibility, straightforward terms, and competitive rates.
24,631 articlesHims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Palantir rides the AI hype as demand grows, but valuation concerns and fears of the AI gold rush eroding its edge kee...
Epic Fury is spreading beyond energy prices, hitting travel, remittances, and food imports in Asia. The resulting pol...
The market has sprinted higher, and valuations feel stretched. History, however, shows that corrections are a normal ...
As investors await a potential new federal reserve chair, analysts say the policy path could lift small-cap stocks. T...
A security audit uncovers a vulnerability in Trezor's secure element. While this raises questions about hardware wall...
A new Washington state law requires residential listings to be publicly marketed, limiting private and exclusive sale...
CrowdStrike is moving to a 4-for-1 stock split. This guide breaks down what the split does, how it affects you as an ...
Nuclear energy is a long game for investors. This guide weighs NuScale Power against Oklo as a path to exposure in th...
Investors chase steady monthly cash without loading up on megacap tech. This piece explains how a Nasdaq-focused inco...
A Speedway employee admitted to processing fake coffee refunds that drained thousands from the chain. The case highli...
Lawmakers warn that granting a national bank charter to a crypto-focused issuer could undermine financial integrity a...